Department of Visual Neuroscience, UCL Institute of Ophthalmology, London, UK.
Neurobiol Dis. 2010 Sep;39(3):344-51. doi: 10.1016/j.nbd.2010.04.019. Epub 2010 May 6.
In the age-related, blinding disease glaucoma, retinal ganglion cells (RGCs) degenerate, possibly affecting glutamatergic retinofugal transmission to the brain. The superior colliculus (SC) is a major central target of retinofugal axons in the rodent, a much used disease model. We investigated the contribution of NMDA-type glutamate receptors to retinocollicular transmission in a rat glaucoma model, using a SC brain slice preparation to determine the sensitivity of synaptic responses to the NMDAR antagonist D-AP5. At 32weeks after induction of experimental glaucoma, but not earlier, there was an increase in NMDAR contribution to SC synaptic responses in slices receiving input from glaucomatous eyes. This suggests that there are changes in NMDAR function after RGC degeneration in experimental glaucoma, which may represent functional SC compensation through plasticity via NMDARs. This has implications for studies carried out using rodent glaucoma models, especially those evaluating potential treatment strategies, as it suggests that functional changes in the central visual system need to be considered in addition to those in the eye. Furthermore, the data underline the need for early therapeutic intervention in order to pre-empt subsequent central functional changes.
在与年龄相关的致盲性疾病青光眼(glaucoma)中,视网膜神经节细胞(retinal ganglion cells,RGCs)会发生变性,这可能会影响谷氨酸能的视网膜传出神经向大脑的传递。上丘(superior colliculus,SC)是啮齿动物视网膜传出轴突的主要中枢靶标,也是一种常用的疾病模型。我们使用 SC 脑切片制备来研究 NMDA 型谷氨酸受体对大鼠青光眼模型中视网膜-丘系传递的贡献,以确定对 NMDAR 拮抗剂 D-AP5 的突触反应敏感性。在诱导实验性青光眼后 32 周,但不是更早的时候,接受来自青光眼眼输入的切片中 SC 突触反应的 NMDAR 贡献增加。这表明在实验性青光眼的 RGC 变性后,NMDAR 功能发生了变化,这可能代表通过 NMDAR 进行可塑性的 SC 功能代偿。这对使用啮齿动物青光眼模型进行的研究具有影响,特别是那些评估潜在治疗策略的研究,因为这表明需要考虑除眼部以外的中枢视觉系统的功能变化。此外,这些数据强调了需要早期进行治疗干预,以防止随后发生中枢功能变化。